TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Eclipse Biofarm AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
14,918
|
16,270
|
15,971 |
| Financial expenses |
238
|
201
|
60 |
| Earnings before taxes |
-232
|
141
|
946 |
| EBITDA |
358
|
610
|
1,231 |
| Total assets |
10,423
|
9,934
|
11,020 |
| Current assets |
8,049
|
7,484
|
9,183 |
| Current liabilities |
6,548
|
5,894
|
7,378 |
| Equity capital |
3,672
|
3,791
|
3,427 |
| - share capital |
206
|
203
|
189 |
| Employees (average) |
5
|
6
|
8 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
35.2%
|
38.2%
|
31.1% |
| Turnover per employee |
2,984
|
2,712
|
1,996 |
| Profit as a percentage of turnover |
-1.6%
|
0.9%
|
5.9% |
| Return on assets (ROA) |
0.1%
|
3.4%
|
9.1% |
| Current ratio |
122.9%
|
127.0%
|
124.5% |
| Return on equity (ROE) |
-6.3%
|
3.7%
|
27.6% |
| Change turnover |
-1,646
|
-834
|
1,347 |
| Change turnover % |
-10%
|
-5%
|
9% |
| Chg. No. of employees |
-1
|
-2
|
3 |
| Chg. No. of employees % |
-17%
|
-25%
|
60% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.